GPT Healthcare Ltd
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiolog… Read more
GPT Healthcare Ltd (GPTHEALTH) - Net Assets
Latest net assets as of September 2025: ₹2.54 Billion INR
Based on the latest financial reports, GPT Healthcare Ltd (GPTHEALTH) has net assets worth ₹2.54 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹4.63 Billion) and total liabilities (₹2.10 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹2.54 Billion |
| % of Total Assets | 54.76% |
| Annual Growth Rate | 13.72% |
| 5-Year Change | 85.1% |
| 10-Year Change | N/A |
| Growth Volatility | 8.68 |
GPT Healthcare Ltd - Net Assets Trend (2017–2024)
This chart illustrates how GPT Healthcare Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for GPT Healthcare Ltd (2017–2024)
The table below shows the annual net assets of GPT Healthcare Ltd from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | ₹2.48 Billion | +13.44% |
| 2023-09-30 | ₹2.18 Billion | +32.13% |
| 2022-09-30 | ₹1.65 Billion | +4.54% |
| 2021-09-30 | ₹1.58 Billion | +18.13% |
| 2020-09-30 | ₹1.34 Billion | +5.58% |
| 2019-09-30 | ₹1.27 Billion | +9.50% |
| 2018-09-30 | ₹1.16 Billion | +14.95% |
| 2017-09-30 | ₹1.01 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to GPT Healthcare Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2133.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹1.15 Billion | 46.51% |
| Common Stock | ₹820.55 Million | 33.11% |
| Other Comprehensive Income | ₹12.25 Million | 0.49% |
| Other Components | ₹492.88 Million | 19.89% |
| Total Equity | ₹2.48 Billion | 100.00% |
GPT Healthcare Ltd Competitors by Market Cap
The table below lists competitors of GPT Healthcare Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RSUPPORT Co. Ltd
KQ:131370
|
$37.90 Million |
|
WTK Holdings Bhd
KLSE:4243
|
$37.91 Million |
|
CLOUDR GROUP LTD.
F:H3L
|
$37.91 Million |
|
Dolat Algotech Limited
NSE:DOLATALGO
|
$37.93 Million |
|
NatureCell Co.Ltd
KQ:007390
|
$37.82 Million |
|
Nyquest Technology Co Ltd
TWO:6494
|
$37.82 Million |
|
Yojee Ltd
AU:YOJ
|
$37.82 Million |
|
Vakrangee Limited
NSE:VAKRANGEE
|
$37.81 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GPT Healthcare Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,184,903,000 to 2,478,506,000, a change of 293,603,000 (13.4%).
- Net income of 499,217,000 contributed positively to equity growth.
- Dividend payments of 287,192,000 reduced retained earnings.
- Other comprehensive income decreased equity by 1.
- Other factors increased equity by 81,578,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹499.22 Million | +20.14% |
| Dividends Paid | ₹287.19 Million | -11.59% |
| Other Comprehensive Income | ₹-1.00 | -0.0% |
| Other Changes | ₹81.58 Million | +3.29% |
| Total Change | ₹- | 13.44% |
Book Value vs Market Value Analysis
This analysis compares GPT Healthcare Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.03x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.21x to 4.03x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-09-30 | ₹37.83 | ₹121.55 | x |
| 2018-09-30 | ₹14.49 | ₹121.55 | x |
| 2019-09-30 | ₹15.87 | ₹121.55 | x |
| 2020-09-30 | ₹16.32 | ₹121.55 | x |
| 2021-09-30 | ₹19.28 | ₹121.55 | x |
| 2022-09-30 | ₹20.15 | ₹121.55 | x |
| 2023-09-30 | ₹27.26 | ₹121.55 | x |
| 2024-09-30 | ₹30.19 | ₹121.55 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GPT Healthcare Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.14%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.01%
- • Asset Turnover: 1.08x
- • Equity Multiplier: 1.55x
- Recent ROE (20.14%) is above the historical average (17.09%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 7.52% | 5.18% | 0.64x | 2.28x | ₹-24.94 Million |
| 2018 | 12.91% | 8.70% | 0.67x | 2.22x | ₹33.70 Million |
| 2019 | 8.64% | 5.17% | 0.69x | 2.43x | ₹-17.26 Million |
| 2020 | 15.75% | 8.71% | 0.76x | 2.37x | ₹77.03 Million |
| 2021 | 26.34% | 12.37% | 1.04x | 2.04x | ₹258.45 Million |
| 2022 | 23.59% | 10.80% | 1.10x | 1.98x | ₹224.71 Million |
| 2023 | 21.86% | 11.96% | 1.16x | 1.58x | ₹259.20 Million |
| 2024 | 20.14% | 12.01% | 1.08x | 1.55x | ₹251.37 Million |
Industry Comparison
This section compares GPT Healthcare Ltd's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $13,861,337,361
- Average return on equity (ROE) among peers: 4.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GPT Healthcare Ltd (GPTHEALTH) | ₹2.54 Billion | 7.52% | 0.83x | $37.86 Million |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $48.02 Billion | 3.13% | 1.38x | $8.72 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $8.87 Billion | 5.90% | 0.85x | $1.48 Billion |
| Fortis Healthcare Limited (FORTIS) | $40.85 Billion | 1.77% | 2.04x | $4.64 Billion |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $307.57 Million |
| Indraprastha Medical Corporation Limited (INDRAMEDCO) | $1.59 Billion | 16.95% | 1.52x | $183.78 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.37 Billion | 12.52% | 1.55x | $345.52 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $14.11 Billion | 23.58% | 0.35x | $1.77 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $7.74 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $5.49 Billion | -11.78% | 1.33x | $7.97 Billion |